All Stories

  1. Assessment of cognitive–motor functions in adults with perceived neuropsychological problems using NIH toolbox after remote biofield energy treatment as non‐pharmacological intervention: A randomized double‐blind placebo controlled trial
  2. Effects of distant biofield energy healing on adults associated with psychological and mental health-related symptoms: a randomized, placebo-controlled, double-blind study
  3. The use of biofield energy therapy as complementary and alternative medicine in human health care system: a narrative review and potential mechanisms
  4. Quantum Biofield Energy Therapy for Psychological and Mental Health Problems
  5. Cannabidiol (CBD) Upregulates Vitamin D3 Receptors (VDRs) Expression That Modulates Cytokines (TNF-α, IL-6), Tissue Elasticity, Cellular Senescence, and Mitochondrial ATP Generation in Human and Rodent Cell Lines
  6. Vitamin D3 Supplementation: Improving Memory, Muscle Function, and Pain in Deficient Rats
  7. Simultaneous identification and quantification of pentacyclic triterpenoids and phenolic compounds from the leaves of Boswellia serrata using LC–MS/MS tandem mass spectrometry
  8. The role of biofield energy treatment on psychological symptoms, mental health disorders, and stress‐related quality of life in adult subjects: A randomized controlled clinical trial
  9. Efficacy of a novel proprietary dietary supplement (TRI 360TM) on psychological symptoms and stress-related quality of life in adult subjects: A randomized controlled clinical trial
  10. Cannabidiol improves thyroid function via modulating vitamin D3 receptor in vitamin D3 deficiency diet-induced rat model
  11. Effects of Cannabidiol Interactions withCYP2R1, CYP27B1, CYP24A1,and Vitamin D3Receptors on Spatial Memory, Pain, Inflammation, and Aging in Vitamin D3Deficiency Diet-Induced Rats
  12. Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats
  13. Impact on Fundamental Physiological Functional Biomarkers after Administration of Biofield Treated Formulation in Unpredictable Chronic Stress (UCS)-Induced Rats
  14. Evaluation of Anti-inflammatory Activity after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  15. Evaluation of Inflammatory Serum Cytokines after Treatment with the Consciousness Energy Healing Based Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley...
  16. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Brain Tissues in Cecal Slurry, LPS and E. Coli-Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  17. Evaluation of Cardiac Performance after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  18. Evaluation of Antioxidative Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  19. Elasticity Profile of Skin, Neuronal, Cardiac, and Skeletal Muscle Cells after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation
  20. Oxidative Stress and Inflammatory Biomarkers Analysis of Biofield Treated Proprietary Test Formulation in Heart Tissues in Cecal Slurry, LPS and E. Coli-induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  21. Anti-Inflammatory Activity of Biofield Energy Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  22. Evaluation of Immunomodulatory Effect of a Novel Test Formulation in D-Galactose-Induced Aging Dysfunction in Sprague Dawley Rats
  23. Racial Differences for Gender, Age and BMI and the Presence of Adenomas in Screening and Surveillance Colonoscopies
  24. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Intestinal Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  25. Evaluation of Renal and Cardioprotective Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  26. LC-MS and GC-MS-Based Assessment of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios of Sulfamethoxazole
  27. Evaluation of Disease Index, Colon Damage Score, and Microbial Analysis of Intestinal Flora after Treatment with the Novel Test Formulation in TNBS-Induced Colitis in Sprague Dawley Rats
  28. Structural Characterization and Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Ofloxacin
  29. Effect of Biofield Treatment on Blood, Hepatic, and Cardiac Biomarkers in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  30. Characterization of the Consciousness Energy Healing Treated Cholecalciferol Using LC-MS and GC-MS Spectrometry
  31. Study of the Consciousness Energy Healing Treatment and It’s Effect on the Isotopic Abundance Ratio of Ascorbic Acid (Vitamin C)
  32. Evaluation of the Isotopic Abundance Ratio of Consciousness Energy Healing Treated L-Tryptophan Using LC-MS Spectrometry
  33. Effect of Consciousness Energy Healing Treatment on the Metal Profile and Properties of Tellurium
  34. Antioxidant Activity of Biofield Treated Proprietary Test Formulation Supplemented with Vitamins and Minerals in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  35. Evaluation of Vitamin D3 metabolite (25-OH Vit D3), Neurotransmitter (ACh), and the Expression of Proinflammatory Cytokines (IL-6 and TNF-α) in Tissue Homogenate after Administration of Biofield Energy Healing-based Novel Proprietary Test Formulation a...
  36. Impact of Consciousness Healing Treatment on Physical, Thermal and Spectroscopic Properties of Copper Chloride
  37. Liquid Chromatography-Mass Spectrometry Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated L-Cysteine
  38. "A Comprehensive Study of Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Berberine Chloride Using LC-MS and GC-MS"
  39. sotopic Abundance Ratio Evaluation of the Consciousness Energy Treated Pyridoxine Using LC-MS and GC-MS Spectrometry
  40. Evaluation of Anti-oxidation and Therapeutic Effect of Biofield Energy Healing Based Novel Test Formulation Using TNBS (Tri Nitro Benzene Sulfonic Acid) - Induced Ulcerative Colitis in Sprague Dawley Rats
  41. Assessment of Physical, Thermal and Spectral Properties of Consciousness Energy Treated Cholecalciferol
  42. Role of Biofield Energy Healing Treatment Based Test Formulation on Colon Cytokines Using TNBS-Induced Ulcerative Colitis in Sprague Dawley Rats
  43. Investigation on the Impact of Biofield Energy Treatment on the Physical, Thermal and Spectroscopic Characteristics of Zinc Chloride
  44. Evaluation of Physicochemical, Spectral and Thermal Properties of Energy of Consciousness Healing Treated Iron Sulphate
  45. Physicochemical, Thermal and Spectroscopic characterization of the Energy of Consciousness Healing Treated Copper Chloride
  46. "Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid"
  47. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of L-Cysteine Using LC-MS Spectrometry
  48. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid Using LC-MS Spectrometry
  49. Influence of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  50. Impact of Biofield Energy Healing Treatment on the Isotopic Abundance Ratio Analysis of Pyridoxine HCl Using LC-MS and GC-MS Spectrometry
  51. Investigation of Impact of Biofield Energy Healing Treatment on Physicochemical, Thermal and Spectral Properties of Magnesium Gluconate
  52. Identification of Endothelin-1 and Nitric Oxide Activity in Aorta, Lung and Kidney after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-Name and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  53. Evaluation of Inflammatory Response after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  54. Neuroprotective (iNOS), fibrinolytic (FDP) Markers Analysis of Biofield Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  55. Evaluation of Inflammatory Serum Biomarkers after Treatment with the Consciousness Energy Healing-Based Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  56. Study of VDR Expression after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation Using Cellular Models
  57. Estimation of Sex Hormone, Blood Profiling, and Histopathological Analysis after Treatment with the Biofield Energy Treated Proprietary Test Formulation in Unpredictable Chronic Stress (UCS)- Induced Sprague Dawley Rats
  58. Evaluation of Vitamin D Receptor (VDR) Expression and Telomerase Activity after Treatment with the Biofield Energy Treated Proprietary Test Formulation in Unpredictable Chronic Stress (UCS)-Induced Sprague Dawley Rats
  59. Assessment of Oral Bioavailability of Vitamin D 3 and Its Metabolite, 25-hydroxy (OH) Vitamin D 3 in Male Sprague Dawley Rats Following a Single Oral Dose of Biofield Energy Treated Vitamin D 3
  60. Study of Behavioral Parameters in Vitamin D3 Deficiency Diet (VDD) Induced Animal Model: An Influence of Biofield Energy Healing Treatment
  61. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  62. The Effect of Novel Proprietary Test Formulation for Immunomodulatory activity by Assessing the CD Biomarkers and Colon Microscopy in TNBS-induced Ulcerative Colitis (UC) Rats Model
  63. The LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Silver Sulfadiazine
  64. Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry
  65. Chromatographic and Spectroscopic Evaluation of the Consciousness Energy Healing Treated Ashwagandha Root Extract
  66. Evaluation of Multiple Vital Serum Biomarkers after Treatment with the Consciousness Energy Healing Based Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  67. Physicochemical, Thermal and Spectroscopic Characterization of the Energy of Consciousness Healing Treated Withania somnifera (Ashwagandha) Root Extract
  68. Antioxidant Activity of Biofield Treated Proprietary Formulation Supplemented with Vitamins and Minerals in D-Galactose Induced Aging Dysfunction in Sprague Dawley Rats
  69. Evaluation of Cardiac Biomarkers after Administration of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  70. Evaluation of Stress Biomakers (Cytokines) in Presence of Unpredictable Chronic Stress (UCS) in Sprague Dawley Rats after Treatment with the Biofield Energy Treated Novel Proprietary Test Formulation
  71. The Isotopic Abundance Ratio of Consciousness Energy Treated L-Tryptophan Using LC-MS Spectrometry
  72. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Lungs Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  73. LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of Consciousness Energy Healing Treated Ofloxacin
  74. Analysis of Isotopic Abundance Ratio of Consciousness Energy Healing Treated Metronidazole Using LC-MS and GC-MS Spectrometry
  75. Assessment of Neurobehavioral and Anti-Aging Effect of the Test Formulation in D-Galactose-Induced aging Dysfunction in Sprague Dawley Rats
  76. Prevention of Aging and Improvement of Longevity and Life-Span in D-Galactose Induced Aging Rats After Treatment with the Biofield Energy Per Se and Biofield Treated Proprietary Test Formulation
  77. Solid and liquid state characterization of tetrahydrocurcumin using XRPD, FT-IR, DSC, TGA, LC-MS, GC-MS, and NMR and its biological activities
  78. Physical, Thermal and Spectroscopic Characterization of the Biofield Energy Treated Zinc Chloride
  79. Comprehensive Analytical Study of Consciousness Energy Treatment on Tocopherol Using GC-MS LC-MS FT-IR UV-Vis and NMR Spectroscopy
  80. Gas Chromatography and Mass Spectroscopy (GC-MS) Based Isotopic Abundance Ratio Evaluation of the Biofield Energy Treated Metronidazole
  81. Consciousness Energy Healing Treatment and Its Impact on the Structural Properties and Isotopic Abundance Ratios of Thiamine
  82. Effect of the Biofield Energy Treated Proprietary Test Formulation for Sleep Biomarkers in the Unpredictable Chronic Stress (UCS) Animal Model
  83. Antiaging, Cognition and Anti-Inflammatory Potential of the Biofield Energy Treatment in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  84. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Cefazolin Sodium Using LC-MS and GC-MS Spectrometry
  85. Improvement of Vitamin D 3 Metabolites Level after Oral Administration of the Biofield Energy Treated Proprietary Test Formulation in Vitamin D 3 Deficiency Diet (VDD) Induced Rat Model
  86. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios (PM+1/PM and PM+2/PM) of Ofloxacin
  87. Influence of Consciousness Energy Healing Treatment on the Properties of Polylactic-co- Glycolic Acid (PLGA)
  88. Evaluation of the physicochemical, thermal and behavioural properties of consciousness energy healing treated iron (II) sulphate
  89. Characterization of the biofield energy treated aluminium using PSA, PXRD, and TGA/DTG analytical techniques
  90. Evaluation of Anti-Aging Activity of the Biofield Energy Treated Novel Test Formulation Using SIRT1 and Telomerase Activity in in Vitro Model
  91. Consciousness Energy Healing Treatment Influenced the Physicochemical Properties of Zinc
  92. "Evaluation of Physicochemical and Thermal Properties of the Consciousness Energy Healing Treated Tellurium"
  93. In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
  94. Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
  95. Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
  96. Antioxidant and Organ Protective Potential of the Consciousness Energy Healing-Based Novel Test Formulation Using Different Biomarkers Analysis
  97. "Assessment of the Biofield Energy Healing Based Test Formulation on Human Organ Health Specific Biomarkers In Vitro Assays"
  98. Powder X-ray Diffraction and Particle Size Analysis of the Consciousness Energy Healing Treated Vanadium Pentoxide (V2O5)
  99. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Zinc
  100. Consciousness Energy Healing Treatment: Physicochemical and Thermal Characterization of Magnesium
  101. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Properties of Pyridoxine HCl
  102. Complementary and Alternative Medicine: Impact of Consciousness Healing Treatment on the Characteristic Properties of Sulfamethoxazole
  103. Physicochemical and Thermal Characterization of Ascorbic Acid: Impact of Biofield Energy Treatment
  104. Physicochemical and Thermal Characterization of the Consciousness Energy Healing Treated Folic acid
  105. Evaluation of Stress Biomarkers after Oral Administration of the Consciousness Energy Healing Treated Novel Herbomineral Formulation in Male Sprague Dawley Rats
  106. Solid State Characterization of the Consciousness Energy Healing Treated Magnesium
  107. Assessment of Biofield Energy Treatment on Lung Health Using Lung Adenocarcinoma Cell Line (A549)
  108. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Cefazolin Sodium
  109. Complementary and Alternative Medicine: Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Treated Metronidazole
  110. Solid State Characterization for a Comparative Evaluation of the Biofield Energy Treated and Un-treated Ascorbic Acid
  111. Evaluation of the Physicochemical and Thermal Properties of Folic Acid: Influence of the Energy of Consciousness Healing Treatment
  112. Flutamide: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Characteristics
  113. Complementary and Alternative Medicine: Evaluation of the impact of Biofield Energy Treatment on L-Cysteine
  114. Spectroscopic and Calorimetric Evaluation of the Biofield Energy Healing Treated Ofloxacin
  115. Effect of the Consciousness Energy Healing Treatment on the Characteristic Properties of Cefazolin Sodium
  116. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Cholecalciferol (Vitamin D3)
  117. In vitro Assessment of the Biofield Treated Test Item on Cardiac Function Using Rat Cardiomyocytes Cell Line (H9c2) via Multiparametric Analysis
  118. Biofield Energy Treatment: Physicochemical and Thermal Characterization of L-Tryptophan
  119. Consciousness Energy Healing Treatment: Spectroscopic and Calorimetric Evaluation of the Biofield Energy Treated Hydroxypropyl β-Cyclodextrin
  120. The Role of Biofield Energy Treated DMEM in Erectile Dysfunction using Detection of Cgmp Levels in Human Endothelial Cell Line
  121. Assessment of Anti-Ageing Potential of Consciousness Energy Healing Treated DMEM and HFF-1 Cells using Cellular Proliferation and Collagen Metabolism Assays
  122. Characterization of the Physicochemical and Thermal properties of the Biofield Energy Treated Flutamide Using PSA, PXRD, TGA/DTG, and DSC Analytical Techniques
  123. Particle Size, Surface Area, Crystallite Size, and Thermal Analysis of Consciousness Energy Healing Treated Selenium
  124. Assessment of the Physicochemical and Thermal Characterization of Biofield Energy Treated Polylactic-co-glycolic acid (PLGA)
  125. Assessment of Hair Growth Treatment with the Consciousness Energy Healing Treated Williams Medium E Using Mouse Vibrissae Hair Follicle Organ Culture
  126. Complementary and Alternative Medicine: Impact of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Withania somnifera Root Extract
  127. Biofield Energy Treatment Based Test Formulation as a Novel and Efficient Approach on Various Biomarkers in human Bones, Heart, Liver, Lungs, and Brain Cells
  128. Investigation of Vital Organ Specific Biomarkers Using CellBased Assays after Treatment with the Biofield Energy Treated Test Formulation
  129. In vitro Evaluation of Immunomodulatory Effects of the Test Formulation by the Estimation of Natural Killer Cells and Phagocytosis Activities
  130. Impact of the Trivedi Effect ® - Energy of Consciousness Healing on the Proliferation of Plant, Mouse and Human Stem Cells
  131. Impact of Biofield Energy Treated DMEM on Mitochondrial Biogenesis Using Myoblast Cell Line, C2C12: Implications for Metabolic Disease
  132. Impact of Biofield Energy Healing Treatment: Evaluation of AntiRheumatoid Activity Using Synovial Sarcoma Cell Line (SW982)
  133. Antioxidant Activity of Biofield Energy Healing (The Trivedi Effect®) Based Formulation in Sprague Dawley Rats
  134. Structural Characterization and Isotopic Abundance Ratios Analysis of Nanocurcumin Treated With Consciousness Energy Healing Treatment
  135. Consciousness Energy Healing Treatment and Its Effect on the Structural Properties and Isotopic Abundance Ratio of Tetrahydrocurcumin
  136. Study of the Effect of Consciousness Energy Healing Treatment on the Natural Product Berberine Chloride
  137. Evaluation of the Outcome of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Magnesium
  138. Impact of the Trivedi Effect® on the Physicochemical Properties of Antimony
  139. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of an Anticancer Drug 6-Mercaptopurine
  140. Biofield Energy Therapy: Role in Multiple Organ Health Specific Biomarkers in Cell-Based Assay
  141. Evaluation of the Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  142. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Silver Sulfadiazine
  143. Wound Healing Activity of Consciousness Energy Healing Treatmenton HFF-1 Cells and DMEM Using Scratch Assay
  144. Hepatoprotective Effect of Biofield Energy Treatment On Tert-Butyl Hydro Peroxide Induced Liver Injury in Hepatocellular Carcinoma Cell Line (HepG2)
  145. Evaluation of the Consciousness Energy Healing Treated Berberine Chloride Using PXRD, PSA, and DSC Analysis
  146. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of 6-Mercaptopurine
  147. In Vitro Assessment of Estrogenic Potential of Biofield Energy Treatment using Human Endometrial Adenocarcinoma Cell Line
  148. The Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Silver Oxide (Ag2O)a
  149. In Vitro Assessment of Biofield Energy Healing Treatment on Hair Growth by Enhanced Proliferation of Human Follicular Dermal Papilla Cells (HFDPCs)
  150. Influence of the Biofield Energy Therapy on the Physicochemical and Thermal Properties of Sulfamethoxazole
  151. Assessment of the Influence of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Lead Using PXRD, PSA, and DSC
  152. Evaluation of the Physicochemical and Thermal Properties of Chromium Trioxide (CrO3): Impact of Consciousness Energy Healing Treatment
  153. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Characteristics of Folic Acid
  154. Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  155. An Investigation of the Consciousness Energy Healing Therapy on Physicochemical and Thermal Properties of Silver Sulfadiazine
  156. Antioxidative Potential of Consciousness Energy Healing Treatment on HepG2 Cells and DMEM after Oxidative Stress Induced by Hydrogen Peroxide
  157. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  158. Effect of the Consciousness Energy Healing Treatment on DMEM for the Proliferation and Differentiation of Human Bone Osteosarcoma Cells to Improve Bone Health
  159. Antiaging Potentia
  160. Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Healing Treated Ofloxacin
  161. Antiaging Potential of Consciousness Energy Healing-Based Novel Proprietary Formulation
  162. Role of Vitamin D3 on Bone Health in Human Bone Osteosarcoma Cells (MG-63): Influence of Biofield Energy Healing Treatment
  163. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Vitamin D3 (Cholecalciferol)
  164. The Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of L-Cysteine
  165. The Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of 6-Mercaptopurine
  166. Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  167. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Lead Using PXRD, PSA, and DSC Analysis
  168. Assessment of Biofield Energy Healing Based Vitamin D3 Effects on Bone Health Parameters
  169. Biofield Energy Treated Vitamin D3 on the Structural Crosslinks, Maturation, and Bone Mineralization
  170. Assessment of Energy of Consciousness Healing on Cell Growth of Plant Stem Cells Callus Culture
  171. "A Comparative Analysis of Vitamin D3 and Biofield Energy Treated Vitamin D3 in Bone Health Using MG-63 Cell Line"
  172. Increase in Bone Mass Density and Overall Bone Health Following High-Impact of Bio-field Energy Treated Vitamin D3inMG-63 Cell Line
  173. Biofield Energy Enriched Vitamin D3 versus Vitamin D3 in Preventing Fractures and Bone Loss
  174. Functional Modification of Bone Tissues After Treatment with the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  175. Role of Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63): A Multidisciplinary Aspect on Bone Health
  176. Vitamin D3 and Consciousness Energy Healing TreatmentModality on Human Osteoblast Cells
  177. The Bone Regenerative Effects of the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  178. Biofield Energy Healing Based Vitamin D3: An Improved Overall Bone Health Activity in MG-63 Cell Line
  179. Influence of the Biofield Energy Treated Vitamin D<sub>3</sub> on Human Osteoblast-Like Cells
  180. Effect of Biofield EnergyTreated Vitamin D3 on the Proliferation of Osteoblast-Like MG-63 Human Osteosarcoma Cells in vitro
  181. Biofield Energy Based Vitamin D<sub>3</sub> Stimulates <i>In vitro</i> Osteoblasts Differentiation in MG-63 Cell line
  182. An <i>In vitro</i> Experiment on Bone Growth and Differentiation in Human Bone Osteosarcoma Cells (MG-63): Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  183. Assessment of Bone Health After Treatment with the Consciousness Energy Healing Treated Vitamin D<sub>3</sub> in Human Bone Osteosarcoma Cells (MG-63)
  184. Biofield Energy Enriched Vitamin D<sub>3</sub>: A New Horizons for Development of Bone Health Using MG-63 Cells
  185. Regulation of Bone Health Parameters After Treatment with Biofield Energy Healing Based Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63)
  186. <i>In vitro</i> Study on Human Bone Osteosarcoma Cells (MG-63): Role of Biofield Energy Treated Vitamin D<sub>3</sub>
  187. Biofield Energy Treated Vitamin D<sub>3</sub>: Therapeutic Implication on Bone Health Using Osteoblasts Cells
  188. The Influence of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health and Its Health Consequences in MG-63 Cell-Line
  189. Effect of Biofield Energized Vitamin D<sub>3</sub> on Bone Health in MG-63 Cell-Line
  190. Regulation of Bone Health Parameters in MG-63 Cell Line After Treatment with Biofield Energy Treated Vitamin D<sub>3</sub>
  191. The Effect of Vitamin D<sub>3</sub> on Bone Mineralization: Influence of Consciousness Energy Healing Treatment
  192. Evaluation of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health Parameters in Human Bone Osteosarcoma Cells (MG-63)
  193. Influence of Biofield Treated Vitamin D<sub>3</sub> on Proliferation, Differentiation, and Maturation of Bone-Related Parameters in MG-63 Cell-Line
  194. A Perspective of Bone Health Study: Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  195. Influenced of Biofield Energy Healing Treatment on Vitamin D<sub>3</sub> for the Assessment of Bone Health Parameters in MG-63 cells
  196. Evaluation of Biofield Energy Treated Vitamin D<sup>3</sup> in Human Osteoblasts Cells
  197. Exploring the Effects of Biofield Energy Treated Vitamin D<sup>3</sup> on Bone Health Parameters in MG-63 Cell Line
  198. The Potential Benefits of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Mineralization in Human Bone Osteosarcoma Cells (MG-63)
  199. Improved Metabolism of Vitamin D<sub>3</sub> in Human Osteoblasts Cells After Biofield Energy Healing Treatment
  200. An Alternative Approach for the Management of Bone Health: Role of Biofield Energy Healing Treated Vitamin D<sub>3</sub>
  201. Effects of Vitamin D<sub>3</sub> on the Proliferation and Mineralization of Human Osteoblast-Like Cells: Implications of Biofield Energy Healing Treatment
  202. Impact of Biofield Energy Healing Treated Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63) for Bone Health
  203. Role of Vitamin D<sub>3</sub> on Alkaline Phosphatase, Collagen, and Bone Mineralization: Impact of Biofield Energy Healing Treatment
  204. Biofield Energy Treated Vitamin D<sub>3</sub>: Direct Effect on Bone Health Using Human Osteoblast-Like Cells
  205. <i>In Vitro</i> Effects of Biofield Energy Treated Vitamin D<sub>3</sub> Supplementation on Bone Formation by Osteoblasts Cells
  206. Energy of Consciousness Healing on Growth and Yield of the Plant Stem Cells Culture
  207. Evaluation of the Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of Flutamide
  208. Influence of the Biofield Energy Healing Treatment on the Physicochemical and Thermal Properties of Metronidazole
  209. Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Hydroxypropyl -Cyclodextrin
  210. Evaluation of the Effect ofBiofield Energy Treatment on Physicochemical and Thermal Properties of Hydroxypropyl β-Cyclodextrin
  211. Enhancement of Hair Growth through Stimulation of Dermal Papilla Cells in Human Follicular Dermal
  212. Improvement of Hair Growth in Mouse Skin by Application of Consciousness Energy Treated Test Item
  213. Effect of Biofield Energy Treatment on Bone Cell Proliferation and Differentiation for the Assessment of its Potential to Improve Bone Health
  214. Physicochemical and Spectroscopic Characterization of Biofield TreatedButylated Hydroxytoluene
  215. Effect of Biofield Energy Treated Cell Growth Medium on Human Fibroblast Cell Growth for Assessment of Skin Health Promotion Potential
  216. Evaluation of Bone Mineral Density and Biochemical Parameters of Bone Metabolism after Treatment with Biofield Energy Treated Vitamin D3 in MG-63 Cells
  217. An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line
  218. In-depth investigation on physicochemical and thermal properties of magnesium (II) gluconate
  219. Immunomodulatory potential of nanocurcumin-based formulation
  220. Role of Vital Trace Elements in Nanocurcumin-Centered Formulation
  221. Characterization of Sodium Selenate Using XRD, PSD, DSC, TGA/DTG, UV-vis, and FT-IR
  222. Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy of Magnesium (II) Gluconate Solution
  223. Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy
  224. Protective effects of tetrahydrocurcumin (THC) on fibroblast and melanoma cell lines in vitro
  225. Withania somnifera based formulation supplemented with minerals in Sprague Dawley rats
  226. Spectral, and Thermal Properties of Sodium Selenate Treated with the Energy of Consciousness
  227. Consciousness Healing Treatment on the Physical, Structural, and Thermal Properties of Zinc Chloride
  228. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  229. Energy Healing Treatment on the Physical, Spectral, and Thermal Properties of Zinc Chloride
  230. Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  231. Structure and Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  232. Withania somnifera (Ashwagandha) Root Extract Treated with the Energy of Consciousness
  233. Properties of Sodium Selenate Treated with the Energy of Consciousness (The Trivedi Effect®)
  234. Properties and Isotopic Abundance Ratio of Biofield Energy Treated Magnesium Gluconate
  235. Evaluation of Isotopic Abundance Ratio and Structural Properties of Magnesium Gluconate
  236. A comprehensive physicochemical, thermal, & spectroscopic characterization of zinc
  237. Herbomineral formulation on pro-inflammatory cytokines expression in mouse splenocyte cells
  238. Evaluation of Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  239. Evaluation of the Energy of Consciousness Healing Treated Withania somnifera Root Extract
  240. Magnesium Gluconate Treated with the Energy of Consciousness Using LC-MS and NMR Spectroscopy
  241. Withania Somnifera (Ashwagandha) Root Extract Using LC-MS, GC-MS, and NMR Spectroscopy
  242. Physical, Spectroscopic, Thermal and Behavioral Properties of Ashwagandha Root Extract
  243. Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  244. Consciousness Energy Healing Treatment on Withania somnifera Root Extract
  245. Evaluation of the Physicochemical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  246. Evaluation of Skin Protective Effect Using in Vitro Cell Line Models of Biofield
  247. Skin Nourishing Effects of Biofield Energy Healing Treatment Based Herbomineral Formulation
  248. Skin Protective Activity of Consciousness Energy Healing Treatment Based Herbomineral Formulation
  249. The Study of Biofield Energy Treatment Based Herbomineral Formulation in Skin Health and Function
  250. Use of Consciousness Energy Healing Based Herbomineral Formulation for Skin Anti-Aging Strategies
  251. Overall Skin Health Potential of the Biofield Energy Healing Based Herbomineral Formulation
  252. Energy Healing Treatment on Herbomineral Formulation in Different Skin Health Parameters
  253. Biofield Energy Healing Based Herbomineral Formulation: An Emerging Frontier in Cosmetic Medicine
  254. Thermal and Behavioral Properties of the Biofield Energy Healing Treated Sodium Selenate
  255. Physicochemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  256. Structural Characterization and Isotopic Abundance Ratio Analysis of Magnesium Gluconate
  257. Healing Treatment on Physical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  258. Consciousness Healing Treated Withania Somnifera Root Extract Using LC-MS, GC-MS, and NMR
  259. Withania somnifera Root Extract Using GC-MS and Nuclear Magnetic Resonance Spectroscopy
  260. Physicochemical, Thermal, Structural, and Behavioral Properties Analysis in Magnesium Gluconate
  261. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  262. Solid State Characterization of Withania somnifera (Ashwagandha) Root Extract
  263. Energy Healing Treatment Based Herbomineral Formulation Against Various Skin Health Parameters
  264. Skin Photo-Protective and Anti-ageing Activity of Consciousness Energy Healing Treatment
  265. An in Vitro Study of Biofield Energy Healing Based Herbomineral Formulation for Skin Protection
  266. Immunomodulatory Response of Herbomineral Formulation in Male Sprague Dawley Rats
  267. Novel Herbomineral Formulation After Oral Administration in Male Sprague Dawley Rats
  268. Characterization of the Consciousness Energy Healing Treated Withania somnifera Root Extract
  269. Analysis of Withania somnifera Root Extract After Treatment with the Energy of Consciousness
  270. Differential Regulation of Immune Biomarkers by the The Trivedi Effect® on Herbomineral Formulation
  271. Immunopotentiating Impact of The Trivedi Effect® on Herbomineral Formulation Oral Administration
  272. Evaluation of the Physico-chemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  273. Impact of Trivedi Effect® on Physicochemical, Thermal, Properties of Magnesium Gluconate
  274. Evaluation of Immunomodulatory Properties After Oral Administration of Biofield Energy Treated Test Formulation in <i>Sprague Dawley</i> Rats: Influence of the Trivedi Effect<sup>®</sup>
  275. Evaluation of the Effects of Biofield Energy Healing Based Herbomineral Formulation on Various Biomarkers in Male <i>Sprague Dawley</i> Rats: Potential Role of the Trivedi Effect<sup>®</sup>
  276. Characterization of Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate After Treatment with the Energy of Consciousness
  277. Evaluation of Immune Biomarkers After Oral Administration of the Novel Herbomineral Formulation Treated with The Trivedi Effect<sup>®</sup> - Biofield Energy Healing in Male <i>Sprague Dawley</i> Rats
  278. Immunomodulatory Activity of Biofield Energy Healing Based Herbomineral Formulation in <i>Sprague Dawley</i> Rats: Evidence for Humoral and Cell-Mediated Responses
  279. An Investigation of The Trivedi Effect<sup>®</sup>-Energy of Consciousness Healing Treatment to Modulate the Immunomodulatory Effect of Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  280. Assessment of Consciousness Energy Healing Treatment on Immune Biomarkers After Oral Administration of Herbomineral Formulation in <i>Sprague Dawley</i> Male Rats
  281. Evaluation of Immune Biomarkers After Oral Administration of Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  282. Evaluation of Immunomodulatory Parameters in Female <i>Sprague Dawley</i> Rats after Oral Administration of the Biofield Energy Healing Treated Herbomineral Formulation
  283. Impact of Biofield Treated Formulation on Immune Biomarkers of Female Sprague Dawley Rats
  284. Investigation of Immune Biomarkers Regulation by Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  285. Modulation of Immune Biomarkers by Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rat: Potential Role of Energy of Consciousness
  286. Effect of Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Novel Herbomineral Formulation on Immune Biomarkers After Oral Administration in Female <i>Sprague Dawley</i> Rats
  287. Immunomodulatory Potential of New Classical Herbomineral Formulation in Experimental Animals: Impact of Biofield Energy Healing Treatment
  288. Assessment of Immunomodulatory Activity of the Biofield Energy Treated Novel Herbomineral Formulation After Oral Administration in Female <i>Sprague Dawley</i> Rats
  289. Characterization of the Physicochemical, Structural, and Thermal Properties of Zinc Chloride After the Consciousness Energy Healing Treatment
  290. Implication of Biofield Energy Healing Based Vitamin D3 on Osteoblastic Differentiation
  291. Improved Bone Health Parameters After Treatment with Consciousness Energy Treated Vitamin D3
  292. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Treated Ortho-Toluic Acid
  293. Biochemical Reactions, and Genotypic Pattern of Biofield Treated Pseudomonas aeruginosa
  294. Thermal, Spectroscopic and Chemical Characterization of Biofield Energy Treated Anisole
  295. Biofield Energy Treated Nitrophenol Derivatives Using Gas Chromatography-Mass Spectrometry
  296. Physicochemical Characterization of Biofield Energy Treated Hi VegTM Acid Hydrolysate
  297. 1,2,3-Trimethoxybenzene (TMB) After Biofield Energy Treatment (The Trivedi Effect®) Using GC-MS
  298. Biofield Energy Treated Resorcinol Using Gas Chromatography-Mass Spectrometry Technique
  299. Isotopic Abundance of 2H, 13C, 18O, and 37Cl in Biofield Energy Treated Dichlorophenol Isomers
  300. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Indole Using GC-MS
  301. 13C/12C or 2H/1H and 18O/16O in Biofield Energy Treated 1-Chloro-3-Nitrobenzene (3-CNB) Using GC-MS
  302. Isotopic Abundance of 13C, 2H, and 18O in Biofield Energy Treated p-tertiary Butylphenol (PTBP)
  303. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Methyl-2-napthylether (Nerolin)
  304. Biofield Energy Treated 1,4-Dichlorobenzene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  305. Biofield Energy Healing (The Trivedi Effect®) Based Herbomineral Formulation in Mouse Splenocytes
  306. Evaluation Mouse Splenocytes After Co-Incubation with the Biofield Energy Treated Formulation
  307. Mouse Splenocyte Cells After Incubation with Biofield Energy Healing Based Herbomineral Formulation
  308. Impact of the Trivedi Effect Herbomineral Formulation on Pro-inflammatory Cytokines Expression
  309. Pro-Inflammatory Cytokines Expression in Murine Dendritic and Splenocyte Cells
  310. Mouse Splenocytes After Incubation with Biofield Treated Herbomineral Formulation
  311. Biofield Energy Signals, Energy Transmission and Neutrinos
  312. Thermal and Physical properties of Biofield Treated Acrylamide and 2-Chloroacetamide
  313. Mouse Dendritic and Splenocyte Cells for Modulation of Pro-inflammatory Cytokines
  314. Effect of a Biofield Treatment on Plant Growth and Adaptation
  315. Effect of Biofield Treatment on the Physical and Thermal Characteristics of Aluminium Powders
  316. Studies of the Atomic and Crystalline Characteristics of Ceramic Oxide Nano Powders after Bio field Treatment
  317. Impact of Biofield Treatment on Physical, Structural and Spectral Properties of Antimony Sulfide
  318. Spectroscopic Characterization of Chloramphenicol and Tetracycline: An Impact of Biofield Treatment
  319. Spectroscopic Characterization of Biofield Treated Metronidazole and Tinidazole
  320. Phenotypic and Biotypic Characterization of Klebsiella oxytoca: An Impact of Biofield Treatment
  321. An Impact of Biofield Treatment on Spectroscopic Characterization of Pharmaceutical Compounds
  322. Biofield Treatment: An Alternative Approach to Combat Multidrug-Resistant Susceptibility Pattern of Raoultella ornithinolytica
  323. Characteristics of Staphylococcus aureus: Impact of Bio field Treatment
  324. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Ammonium Acetate and Ammonium Chloride: An Impact of Biofield Treatment
  325. Characterization of Physical, Thermal and Structural Properties of Chromium (VI) Oxide Powder: Impact of Biofield Treatment
  326. Influence of Biofield Treatment on Physicochemical Properties of Hydroxyethyl Cellulose and Hydroxypropyl Cellulose
  327. Characterization of Physical, Spectral and Thermal Properties of Biofield Treated 1,2,4-Triazole
  328. Antibiogram Typing and Biochemical Characterization of Klebsiella pneumoniae after Biofield Treatment
  329. Impact of Biofield Treatment on Yield, Quality and Control of Nematode in Carrots
  330. An Impact of Biofield Treatment: Antimycobacterial Susceptibility Potential Using BACTEC 460/MGIT-TB System
  331. Physical, Thermal and Spectroscopic Characterization of m-Toluic Acid: an Impact of Biofield Treatment
  332. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Biofield Treated Salicylic Acid and Sparfloxacin
  333. Physical and Structural Characterization of Biofield Treated Imidazole Derivatives
  334. Evaluation of Physical, Thermal and Spectroscopic Properties of Biofield Treated p-Hydroxyacetophenone
  335. An Effect of Biofield Treatment on Multidrug-resistant Burkholderia Cepacia: A Multihost Pathogen
  336. Characterization of Physico-Chemical and Spectroscopic Properties of Biofield Energy Treated 4-Bromoacetophenone
  337. Physicochemical and Spectroscopic Characterization of Biofield Treated Triphenyl Phosphate
  338. Physical and Structural Characterization of Biofield Energy Treated Carbazole
  339. Evaluation of Biofield Treatment on Atomic and Thermal Properties of Ethanol
  340. Characterisation of Physical, Spectral and Thermal Properties of Biofield treated Resorcinol
  341. Physicochemical and Atomic Characterization of Silver Powder after Biofield Treatment
  342. Spectroscopic Characterization of Disodium Hydrogen Orthophosphate and Sodium Nitrate after Biofield Treatment
  343. Characterization of Physical and Structural Properties of Aluminium Carbide Powder: Impact of Biofield Treatment
  344. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen
  345. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Methyl-2-Naphthyl Ether
  346. Antimicrobial Sensitivity, Biochemical Characteristics and Biotyping of Staphylococcus saprophyticus: An Impact of Biofield Energy Treatment
  347. Physical, Thermal and Spectral Properties of Biofield Treated 1,2,3-Trimethoxybenzene
  348. Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen
  349. Physical, Thermal and Spectroscopic Characterization of Biofield Treated p-Chloro-m-cresoln
  350. Evaluation of Phenotyping and Genotyping Characteristic of Shigella sonnei after Biofield Treatment
  351. Effect of Biofield Treatment on Phenotypic and Genotypic Characteristic of Provindencia rettgeri
  352. The Potential Impact of Biofield Treatment on Human Brain Tumor Cells: A Time-Lapse Video Microscopy
  353. An Evaluation of Biofield Treatment on Susceptibility Pattern of Multidrug Resistant Stenotrophomonas maltophilia: An Emerging Global Opportunistic Pathogen
  354. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2, 6-Diaminopyridine
  355. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated O-Aminophenol
  356. Characterization of Physicochemical and Thermal Properties of Chitosan and Sodium Alginate after Biofield Treatment
  357. Biofield Energy Treatment: A Potential Strategy for Modulating Physical, Thermal and Spectral Properties of 3-Chloro-4-fluoroaniline
  358. The Potential Impact of Biofield Energy Treatment on the Physical and Thermal Properties of Silver Oxide Powder
  359. In vitro Evaluation of Biofield Treatment on Enterobacter cloacae: Impact on Antimicrobial Susceptibility and Biotype
  360. Evaluation of Biofield Modality on Viral Load of Hepatitis B and C Viruses
  361. Physical and Thermal Properties of O-Nitrophenol, M-Nitrophenol and P-Tertiary Butyl Phenol
  362. Impact of Biofield Treatment on Chemical and Thermal Properties of Cellulose and Cellulose Acetate
  363. Antibiogram Pattern of Shigella flexneri: Effect of BioField Treatment
  364. Physical, Thermal and Spectral Properties of Biofield Energy Treated 2,4-Dihydroxybenzophenone
  365. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Energy Treated p-Phenylenediamine and p-Toluidine
  366. Characterization of Phenotype and Genotype of Biofield Treated Enterobacter aerogenes
  367. Evaluation of Antibiogram, Genotype and Phylogenetic Analysis of Biofield Treated Nocardia otitidis
  368. Potential Impact of BioField Treatment on Atomic and Physical Characteristics of Magnesium
  369. Evaluation of Thermal and Physical Properties of Magnesium Nitride Powder: Impact of Biofield Energy Treatment
  370. Influence of Biofield Treatment on Physical and Structural Characteristics of Barium Oxide and Zinc Sulfide
  371. The Potential Impact of Biofield Treatment on Physical, Structural and Mechanical Properties of Stainless Steel Powder
  372. Effect of Biofield Treatment on Antimicrobials Susceptibility Pattern of Acinetobacter baumannii
  373. Antibiogram and Genotypic Analysis using 16S rDNA after Biofield Treatment on Morganella morganii
  374. Investigation of Biofield Treatment on Antimicrobial Susceptibility, Biochemical Reaction Pattern and Biotyping of Enteropathogenic Multidrug-Resistant Escherichia coli Isolates
  375. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  376. Assessment of Antibiogram of Multidrug-Resistant Isolates of Enterobacter aerogenes after Biofield Energy Treatment
  377. Characterization of Biofield Energy Treated 3-Chloronitrobenzene: Physical, Thermal, and Spectroscopic Studies
  378. Impact of Biofield Energy Treatment on Soil Fertility
  379. Influence of Biofield Energy Treatment on Isotopic Abundance Ratio in Aniline Derivatives
  380. Studies on Physicochemical Properties of Biofield Treated 2,4-Dichlorophenol
  381. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Potato Micropropagation Medium
  382. Evaluation of Biofield Treated Peptone And Malmgren Modified Terrestrial Orchid Medium
  383. Physical, Thermal and Spectral Properties of Biofield Treated 3-Nitroacetophenone
  384. Thermal, Spectroscopic and Chromatographic Characterization of Biofield Energy Treated Benzophenone
  385. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2-Aminopyridine
  386. Characterization of Physical, Spectroscopic and Thermal Properties of Biofield Treated Biphenyl
  387. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2,6-Dichlorophenol
  388. Physicochemical and Spectral Characterization of Biofield Energy Treated 4-Methylbenzoic Acid
  389. Chromatographic, Spectroscopic, and Thermal Characterization of Biofield Energy Treated N,N-Dimethylformamide
  390. Physicochemical Characterization of Biofield Energy Treated Calcium Carbonate Powder
  391. Molecular Analysis of Biofield Treated Eggplant and Watermelon Crops
  392. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated p-Anisidine
  393. Characterization of Physical and Thermal Properties of Biofield Treated Neopentyl glycol
  394. Physical, Thermal and Spectral Parameters of Biofield Energy Treated Methylsulfonylmethane
  395. Antibiogram Typing of Biofield Treated Multidrug Resistant Strains of Staphylococcus Species
  396. Analysis of Physical, Thermal, and Structural Properties of Biofield Energy Treated Molybdenum Dioxide
  397. Physical and Structural Properties of Calcium Carbide and Praseodymium Oxide
  398. Physicochemical and Spectroscopic Characteristics of Biofield Treated p-Chlorobenzophenone
  399. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated Date Palm Callus Initiation Medium
  400. Biofield Energy Treatment on Physical and Thermal Characteristics of Selenium Powder
  401. Morphological Characterization, Quality, Yield & DNA Fingerprinting of Energy Treated Alphonso Mango
  402. Escherichia coli for Antimicrobial Susceptibility, Biochemical Reaction and Biotyping
  403. Evaluation of Isotopic Abundance Ratio in Naphthalene Derivatives After Biofield Energy Treatment
  404. Improved Susceptibility Pattern of Antimicrobials Using Vital Energy Treatment on Shigella sonnei
  405. Biochemical Differentiation & Molecular Characterization of Biofield Treated Vibrio parahaemolyticus
  406. Physical, Thermal and Spectroscopical Characterization of Biofield Treated Triphenylmethane: An Impact of Biofield Treatment
  407. Experimental Investigation on Physical, Thermal and Spectroscopic Properties of 2-Chlorobenzonitrile: Impact of Biofield Treatment
  408. Characterization of Biofield Energy Treated Murashige and Skoog Plant Cell Culture Media
  409. Physicochemical and Spectroscopic Characterization of Yeast Extract Powder After the Biofield Energy Treatment
  410. Physical, Spectroscopic and Thermal Characterization of Biofield Treated Fish Peptone
  411. Physicochemical and Spectroscopic Properties of Biofield Energy Treated Protose
  412. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated Gerbera Multiplication Medium
  413. Biofield Treated Phosphate Buffer Saline and Hanks Balanced Salt Medium
  414. Characterization of Physicochemical and Spectroscopic Properties of Biofield Energy Treated Bio Peptone
  415. Spectral and Thermal Properties of Biofield Energy Treated Cotton
  416. Effect of Biofield Treated Energized Water on the Growth and Health Status in Chicken
  417. In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in Endometrial and Prostate Cancer Cell Lines
  418. Characterization of Atomic and Physical Properties of Biofield Energy Treated Manganese Sulfide Powder
  419. Assessment of Antibiogram of Biofield Energy Treated Serratia marcescens
  420. Biofield Treatment on Viral Load Against Human Immunodeficiency-1 and Cytomegalo Viruses
  421. Antibiogram, Biochemical Reactions and Biotyping of Biofield Treated Providencia rettgeri
  422. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using GC-MS
  423. Phenotyping and Genotyping Characterization of Proteus vulgaris After Biofield Treatment
  424. Plant Growth Regulator, Immunity and DNA Fingerprinting of Biofield Energy Treated Mustard Seeds
  425. Agronomic Characteristics, Growth Analysis, and Yield Response of Biofield Treated Mustard, Cowpea, Horse Gram, and Groundnuts
  426. Physical, Thermal and Spectroscopic Studies of Biofield Treated p-Chlorobenzonitrile
  427. Effect of Biofield Treatment on Physical, Thermal, and Spectral Properties of SFRE 199-1 Mammalian Cell Culture Medium
  428. Biochemical Marker – Glutathione and DNA Fingerprinting of Biofield Energy Treated Oryza sativa
  429. Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections
  430. Morphological and Molecular Analysis Using RAPD in Biofield Treated Sponge and Bitter Gourd
  431. Antibiogram, Biochemical Reactions and Genotyping Characterization of Biofield Treated <i>Staphylococcus aureus</i>
  432. Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives
  433. Vegetative Growth Parameters in Biofield Treated Bottle Gourd (Lagenaria siceraria) & Okra
  434. Genetic Diversity Using SSR Markers & Growth Regulator Response in Biofield Treated Cotton
  435. Ratio of 13C, 2H, and 18O in Biofield Energy Treated Ortho and Meta Toluic Acid Isomers
  436. Plant Growth, Yield and Yield Attributes of Biofield Energy Treated Mustard and Chick Pea Seeds
  437. Antimicrobial Susceptibility of Proteus mirabilis: Impact of Biofield Energy Treatment
  438. Bacterial Identification Using 16S rDNA Gene Sequencing and Antibiogram Analysis on Biofield Treated Pseudomonas fluorescens
  439. Impact of Biofield Treatment on Spectroscopic and Physicochemical Properties of p-Nitroaniline
  440. Physicochemical and Spectroscopic Characterization of p-Chlorobenzaldehyde: An Impact of Biofield Energy Treatment
  441. Evaluation of Atomic, Physical and Thermal Properties of Tellurium Powder: Impact of Biofield Energy Treatment
  442. Antibiogram of Multidrug-Resistant Isolates of Pseudomonas aeruginosa after Biofield Treatment
  443. Characterization of Antimicrobial Susceptibility Profile of Biofield Treated Multidrug-resistant Klebsiella oxytoca
  444. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii
  445. Antimicrobial Susceptibility, Biochemical Characterization and Molecular Typing of Biofield Treated Klebsiella pneumoniae
  446. Modification of Physical and Thermal Properties of Gluten Hydrolysate and Ipomoea Macroelements
  447. Investigation of Isotopic Abundance Ratio of Biofield Treated Phenol Derivatives Using Gas Chromatography-Mass Spectrometry
  448. Physical, Atomic and Thermal Properties of Biofield Treated Lithium Powder
  449. Potential Impact of Biofield Energy Treatment on the Atomic, Physical and Thermal Properties Indium Powder
  450. Evaluation of Phenotyping and Genotyping Characterization of Serratia marcescens after Biofield Treatment
  451. Physical, Spectroscopic and Thermal Characterization of Biofield treated Myristic acid
  452. Physical, Thermal and Spectroscopic Studies on Biofield Treated p-Dichlorobenzene
  453. Antimicrobial Susceptibility Pattern, Biochemical Characteristics and Biotyping of Salmonella paratyphi A: An Impact of Biofield Treatment
  454. Spectroscopic Characterization of Disulfiram and Nicotinic Acid after Biofield Treatment
  455. Biofield Treatment: A Potential Strategy for Modification of Physical and Thermal Properties of Indole
  456. Impact of Biofield Treatment on Atomic and Structural Characteristics of Barium Titanate Powder
  457. An Evaluation of Biofield Treatment on Thermal, Physical and Structural Properties of Cadmium Powder
  458. Characterization of Physical and Structural Properties of Brass Powder After Biofield Treatment
  459. Influence of Biofield Treatment on Physical, Structural and Spectral Properties of Boron Nitride
  460. Thermal and Physical Properties of Biofield Treated Bile Salt and Proteose Peptone
  461. Effect of Biofield Treatment on Spectral Properties of Paracetamol and Piroxicam
  462. Structural and Physical Properties of Biofield Treated Thymol and Menthol
  463. Effect of Biofield Treatment on Structural and Morphological Properties of Silicon Carbide
  464. Evaluation of Bio-field Treatment on Physical and Structural Properties of Bronze Powder
  465. Evaluation of the Impact of Biofield Treatment on Physical and Thermal Properties of Casein Enzyme Hydrolysate and Casein Yeas t Peptone
  466. Evaluation of Biofield Treatment on Physical, Atomic and Structural Characteristics of Manganese (II, III) Oxide
  467. Antimicrobial Sensitivity Pattern of Pseudomonas fluorescens after Biofield Treatment
  468. An Effective Strategy to Improve the Quality of Beef Extract and Meat Infusion Powder
  469. In Vitro Evaluation of Antifungal Sensitivity Assay of Biofield Energy Treated Fungi
  470. Atomic, Crystalline and Powder Characteristics of Treated Zirconia and Silica Powders
  471. Bio Field Treatment on the Physical and Thermal Characteristics of Vanadium Pentoxide Powders
  472. IMPACT OF BIOFIELD TREATMENT ON GINSENG AND ORGANIC BLUEBERRY YIELD
  473. Biofield Treatment on the Physical and Thermal Characteristics of Silicon, Tin and Lead Powders
  474. Impact of Biofield Treatment on Growth and Anatomical Characteristics of Pogostemon cablin (Benth.)
  475. Thought Intervention through Biofield Changing Metal Powder Characteristics Experiments on Powder Characterisation at a PM Plant
  476. atomic, crystalline and powder characteristics of carbon allotrope powders
  477. atomic, crystalline and powder characteristics of antimony and bismuth powders
  478. Impact of an external energy on Yersinia enterocolitica [ATCC –23715]
  479. A transcendental to changing metal powder characteristics